Segregation analysis of apolipoprotein A1 levels in families of adolescents: A community-based study in Taiwan by Chien, Kuo-Liong et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Genetics
Open Access Research article
Segregation analysis of apolipoprotein A1 levels in families of 
adolescents: A community-based study in Taiwan
Kuo-Liong Chien1,2, Wei J Chen3, Hsiu-Ching Hsu2, Ta-Chen Su2, Ming-
Fong Chen2 and Yuan-Teh Lee*2
Address: 1Institute of Preventive Medicine, School of Public Health, National Taiwan University, Taipei, Taiwan, 2Department of Internal 
Medicine, National Taiwan University Hospital, Taipei, Taiwan and 3Institute of Epidemiology, College of Public Health, National Taiwan 
University, Taipei, Taiwan, Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan
Email: Kuo-Liong Chien - klchien@ha.mc.ntu.edu.tw; Wei J Chen - weijen@ha.mc.ntu.edu.tw; Hsiu-Ching Hsu - hhching@ha.mc.ntu.edu.tw; 
Ta-Chen Su - tachensu@ha.mc.ntu.edu.tw; Ming-Fong Chen - mfchen@ha.mc.ntu.edu.tw; Yuan-Teh Lee* - ytlee@ha.mc.ntu.edu.tw
* Corresponding author    
Background: Apolipoprotein (Apo) A1 is a protective factor for cardiovascular events. This study
aimed to perform complex segregation analyses of Apo A1 levels in families of adolescents
systematically ascertained from the junior high school students in a rural community. Both siblings
and parents of the adolescent probands were recruited for the study. Apo A1 concentrations were
measured by turbidimetric immunoassay methods. After adjustment for gender, age, body mass
index, smoking and drinking status, residual values of Apo A1 were subjected to subsequent
analyses.
Results: Significant mother-father and parent-offspring correlations were found. Commingling
analyses indicated that a four-component distribution model was needed to account for the Apo
A1 variation. Segregation analysis using regressive models revealed that the best-fit model of Apo
A1 was a model of environmental effect plus familial correlation (heritability = 23.9%), in which a
significant mother-father correlation existed. Models containing major gene effect could be
rejected.
Conclusion: These results suggest that variations of Apo A1 levels in the normal range, especially
during adolescence, are likely to be influenced by multiple factors without significant contribution
from major genes.
Background
Apolipoprotein (Apo) A1, one of the structural proteins in
high-density lipoprotein particles, is a protective factor
against the development of atherosclerotic vascular dis-
ease [1,2]. It promotes cholesterol efflux from cells and
maintains cellular cholesterol homeostasis. Although the
structure of Apo A1 and its corresponding genetic locus
have been well characterized [3,4], the levels of Apo A1
are influenced by factors that remain largely unknown.
Determinants of Apo A1 concentrations such as gender,
age, obesity, and lifestyles, account for only a small pro-
portion of the variance (at most 7%) [5-7]. The DNA pol-
ymorphisms of the Apo A1 gene affect Apo A1
concentrations only mildly [8]. Meanwhile, significant
genetic contribution to Apo A1 concentrations is indi-
cated by results from family and twin studies [9,10]. The
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Table 1: Basic demographic and atherosclerotic risk profiles in this family study, specified by generations (n = 1,145)
Probands (N = 368) Siblings (N = 333) Parents (N = 444)
Mean SD Skewness Kurtosis Mean SD Skewness Kurtosis Mean SD Skewness Kurtosis
Age (years) *** 16.45 0.97 0.33 0.34 17.83 3.43 0.59 1.05 43.65 5.74 1.35 4.65
BW (kg) *** 54.07 12.87 1.04 1.48 52.57 11.03 0.93 2.54 62.87 11.93 1.08 6.02
BH (cm) 161.28 8.46 -0.06 0.03 161.27 8.95 -0.01 1.06 160.90 7.68 0.07 -0.31
BMI (kg/m2) *** 20.63 3.87 1.13 1.24 20.08 3.13 1.31 4.26 24.23 3.91 1.03 4.40
SBP (mmHg) *** 108.86 13.02 0.34 -0.34 111.65 12.90 0.36 0.27 119.13 15.12 0.82 1.28
DBP (mmHg) *** 67.79 9.33 -0.05 -0.75 70.66 10.36 0.18 0.51 78.48 11.46 0.70 0.68
TC (mg/dL) *** 168.98 36.43 1.78 11.91 164.94 33.17 0.74 0.70 195.85 35.76 0.29 0.54
TG (mg/dL) *** 85.49 40.14 1.92 7.98 88.86 43.67 2.96 18.43 156.24 134.29 2.66 8.26
HDL-C (mg/dL) * 43.49 10.44 0.50 0.23 44.21 9.55 0.46 0.07 42.26 11.02 0.72 0.77
LDL-C (mg/dL) *** 79.67 32.08 0.61 0.33 86.24 35.61 1.35 4.74 122.13 36.22 0.26 0.61
Apo A1 (mg/dL) *** 108.84 18.19 1.17 4.69 116.49 21.59 1.23 2.81 122.85 23.07 1.06 6.53
Apo B (mg/dL) *** 46.76 13.39 0.35 1.80 49.70 13.87 0.14 0.46 64.53 18.85 1.64 5.32
Smoking *** 1 (0.3%) 35 (10.5%) 159 (35.8%)
Alcohol drinking *** 1 (0.3%) 25 (7.5%) 173 (39.0%)
*: p < 0.05, ** p < 0.01, *** p < 0.001 among group difference by ANOVA (for continuous variables) or chi-square test (for categorical variables). Abbreviated: BMI: body mass index, SBP: systolic 
blood pressure, DBP: diastolic blood pressure, BH: body height, BW: body weight, TC: total cholesterol, TG: triglyceride, HDL-C: high density lipoprotein cholesterol; LDL-C: low density 
lipoprotein cholesterol, Apo: apolipoprotein.BMC Genetics 2006, 7:4 http://www.biomedcentral.com/1471-2156/7/4
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mode of inheritance for Apo A1 concentrations, however,
remains to be clarified.
The mode of inheritance as revealed by complex segrega-
tion analysis (CSA) can provide evidence whether there is
a major gene effect for Apo A1 concentrations, which is
important for subsequent gene localization [11]. Even if
some major susceptibility genes are already identified,
CSA can help shed light on whether other genes exist [12].
So far studies of CSA on Apo A1 concentrations have been
conducted mainly in different samples such as from hos-
pital-based patients or community-based adults, with
conflicting findings reported [7,8,13-18]. First, earlier CSA
in families of probands who either had coronary heart dis-
eases or underwent cardiac catheterization tended to sup-
port the existence of major gene effect for Apo A1
concentrations [15,16]. However, a recent study with a
large sample in relatives of probands who underwent car-
diac angiography failed to find evidence for the major
gene effect [8]. Second, two studies in families of adult
probands identified from the community found evidence
for major gene effect for Apo A1 concentrations [7,17].
But in the HERITAGE Family study, Both Apo A1 at base-
line (sedentary state) and its response the training, the
major gene was not inferred due to the ambiguous trans-
mission of the major effect from parents to offspring after
they followed a supervised exercise training program for
20 weeks [18].
Two reasons for these inconsistent results are possible.
First, since coronary heart diseases have a variety of etiol-
ogies and indications for angiography examinations vary,
ascertaining probands under these clinical conditions
would likely lead to etiological heterogeneity in terms of
ApoA1 concentrations. Second, gene-environmental
interaction may have an important role in the variation of
Apo A1 levels and be more prevalent in the adulthood.
One way to overcome these limitations is to conduct CSA
in families of younger subjects who do not have clinical
symptoms and are systematically ascertained. In this study
we employed this approach to recruit adolescent
probands and their first-degree relatives from a Taiwanese
rural community. The study aimed to assess the possible
mechanisms of genetic contribution to Apo A1 concentra-
Table 2: Familial correlation coefficients of residual Apo A1 
levels in this family study
Correlation in Apo A1
No. of pairs Equal weight 
to pairs
Equal weight to 
pedigrees
Mother-Father 156 0.218 0.218
Parental-Offspring 893 0.122 0.103
Sibling 450 0.119 0.128
Mother-Daughter 240 0.181 0.188
Mother-Son 216 0.107 0.091
Father-Daughter 233 0.087 0.046
Father-Son 204 0.109 0.105
Sister-Sister 136 0.231 0.158
Sister-Brother 221 0.079 0.111
Brother-Brother 93 -0.002 0.037
Table 3: Parameter estimates from segregation analysis of residual Apo A1 levels under Class D regressive models, conditional on 
proband phenotypes
Model Sporadic Familial correlations Environmental Mendelian General
qA [1] [1] 0.974 0.854 0.976
τAA - - =qA [1] 0.971
τAB - - =qA [0.5] 0.989
τBB - - =qA [0] 1.000
AA 118.0 118.4 115.8 118.2 115.9
AB = AA = AA 167.2 114.2 167.3
BB = AA = AA 287.7 195.9 287.8
σ2 492.9 493.2 331.9 390.3 333.3
ρMF [0] 0.240 0.302 0.267 0.301
ρMO [0] 0.129 0.263 0.204 0.266
ρFO [0] 0.081 0.148 0.149 0.148
ρSS [0] 0.000 0.114 0.088 0.115
P a r a m e t e r  # 2699 1 2
-2ln(L) 6453.22 6435.17 6327.62 6361.51 6327.32
AIC 6457.22 6447.17 6345.62 6370.51 6351.32
χ2 125.9 107.85 0.30 34.19 -
P 0.000 0.000 0.960 0.000 -
Abbreviation: #, number of parameters; SEM, standard error of mean; qA, gene frequency; τAA, τAB, τBB, transmission probability; µAA, µAB, 
µBB, genotype means; σ2, variance; ρMF, ρMO, ρFO, ρSS, correlation coefficients among spouse, mother-offspring, father-offspring and sibling pairs; 
#, number of parameters; ln(L), logarithm of likelihood; AIC, Akaike information criteria; P, significance level compared with the unrestricted 
general model.BMC Genetics 2006, 7:4 http://www.biomedcentral.com/1471-2156/7/4
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tions through a series of family-genetic analyses, includ-
ing familial correlation, commingling analysis, and CSA.
Results
There were 368 probands, 333 siblings and 444 parents in
this study. Their distributions on demographic and
atherosclerotic risk variables were presented in Table 1. All
subjects had average body fatness (mean BMI values of 20
in the probands and siblings, and 24 in the parents). The
parents had higher blood pressure, lipid profiles, and
smoking and drinking rates than the probands and sib-
lings. In addition, the parents had larger standard devia-
tions in BMI, blood pressure and lipid profiles, especially
in triglyceride, than their offspring. The values of skew-
ness and kurtosis showed that Apo A1, Apo B, and triglyc-
eride values were not normally distributed.
Proportion of Apo A1 variation in this sample explained
by gender, age, age2, BMI, smoking and drinking habits
was only 7.3%. The correlation between residual Apo A1
concentrations among family members after adjustment
for nonlipid covariates is displayed in Table 2. The
mother-father correlation coefficient was relatively high
as compared with other familial correlations, indicating a
strong environment effect and a weak genetic effect on
Apo A1 levels. It is possible that there is a sex-specific
influence in the variation of Apo A1 levels in the study
subjects. The mother-daughter (0.18) and sister-sister
(0.23) correlations were higher than father-son (0.11),
brother-brother (0.00) or cross-sex correlations for the
variation in Apo A1 levels.
Commingling analysis showed that a 4-component rather
than a single, two or three-component distribution was
the best-fit model for Apo A1 variance. The component
means, variances, and proportions for the 4-component
distribution model were (-0.741, 0.036, 1.142, 2.124),
(0.167, 0.593, 4.813, 0.066), and (18.6%, 73.8%, 5.2%,
2.4%), respectively. The χ2 for comparing the 4-compo-
nent with 3-component distribution was 14.21 (df = 3, p
= 0.003), while that for comparing the 4-component with
5-component distribution was 4.31 (df = 3, p = 0.230).
The finding of multiple distributions is compatible with a
major gene hypothesis; however, commingling may also
arise through other causes. Thus, segregation analysis was
used to determine whether these major effects segregated
in families according to Mendelian expectations.
The results of complex segregation analysis of Apo A1 are
presented in Table 3. The sporadic model, familial corre-
lations model, and Mendelian model were rejected due to
a P value for each model's χ2 of less than 0.001. The envi-
ronmental model is the best-fit one. Under this model,
factor A is pervasively present in the population (fre-
quency = 0.97) and the mother-father correlation coeffi-
cient was 0.30. The mother-offspring correlation was
higher than the father-offspring correlation (0.26 vs.
0.15). If the four familial correlations in the general
model were reduced to two (ρMF = 0.28 ρMO = ρFO = ρSS
= 0.18), the fit was not significantly worse (-2lnL =
6332.82, χ2 = 5.50, df = 2, P = 0.064). The estimated her-
itability was 23.9%.
To rule out the possibility that our rejection of the major
gene effect was due to numerical failure, sensitivity analy-
sis of likelihood values was conducted for the Mendelian
model. The results are plotted in Figure 1. Only three ini-
tial values can reach the global maximum, and the likeli-
hood curves were irregular. The model with parameters
estimated under this global maximum could still be
rejected as it was compared with the general model.
Genetic heterogeneity was tested by plotting -2ln(LE/LM),
in which LE refers to the likelihood of the environmental
model and LM to that of the Mendelian model (Figure 2).
One outlier (i.e., a value of 25.52 for -2ln(LE/LM)) was
found favoring the Mendelian model. A repeated segrega-
tion analysis after excluding this outlier demonstrated
that the environmental model was still the best-fit model.
Discussion
This study clearly demonstrated that there were significant
familial aggregation and commingling components in
Apo A1 concentrations among families of adolescents.
However, we found that the environmental model that
allows for familial correlation rather than the Mendelian
model explained the familial aggregation of Apo A1 best.
Sensitivity analysis of -2lnL by initial gene frequency values  from 0.01 to 0.99, in steps of 0.01, under the Mendelian  model of residual Apo A1 levels in this family study Figure 1
Sensitivity analysis of -2lnL by initial gene frequency values 
from 0.01 to 0.99, in steps of 0.01, under the Mendelian 
model of residual Apo A1 levels in this family study.
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Two main features of this study are worth noting. First,
there is considerable homogeneity in this study popula-
tion. Most of the subjects live in the same community,
hence their social and living environments tended to be
more similar than those in different communities. Sec-
ond, the results are particularly relevant for a population
at low risk for atherosclerosis, since the probands were
randomly selected from adolescents in the community.
Our results were consistent with those of previous familial
correlation and commingling studies [19], which demon-
strated that more than one component is needed to
explain the distribution of lipids. Previous estimates for
the heritability of Apo A1 were 0.2 to 0.3 [20,21]. The
high mother-father correlation found in this study indi-
cated that there might be assortative mating and/or com-
mon household factors affecting Apo A1 concentrations.
We found there were 6.04% parents who knew their
hyperlipidemia disease, and less than 1% had history of
coronary heart disease. There were only 1.65% parents
taking regular hypolipidemic drugs. We think the effects
of lipid-lowering drugs were minimal for parent's lipid
profiles. We found that the correlation between mother
and offspring over Apo A1 was greater than the correlation
between father and offspring. Similar results were
reported in HDL cholesterol concentrations [22]. Similar-
ity in patterns of lifestyle and physical activity among fam-
ily members may explain the effects of assortative mating
and common household effects [23].
The mode of inheritance of Apo A1 concentrations in this
study was best explained by a model of mixed environ-
mental effect and familial correlation. No major gene
effect was found. This is similar to the finding of a recent
study [18] but contrary to the findings from two studies in
families of adult probands identified from the community
[7,17]. Several reasons may account for the lack of major
gene effect in this study. First, it may reflect the complexity
of Apo A1 metabolism. Although Apo A1 is the direct
product of a single gene, it is distributed across the full
range of HDL particles and other lipoproteins as well.
Therefore, Apo A1 concentrations are likely to be influ-
enced by many genetic as well as environmental factors.
Hence, this renders the detection of any singular effect of
a major gene difficult. Intriguingly, CSA of HDL choles-
terol, one phenotype strongly related to Apo A1, also
revealed that the environmental model was the best-fit
model [24]. Second, there might still be residual con-
founding on Apo A1 levels from covariates that were not
controlled for in this study, such as physical activity and
hormone replacement. Third, there were no extreme Apo
A1 levels found in this population. Thus, for variation of
Apo A1 within the normal range, there might be no major
gene effect of considerable magnitude. Finally, the differ-
ent study population characteristics were one possible rea-
son for incongruent results on the mode of inheritance
studies of HDL cholesterol and Apo A1 levels, and this
study was presented as subjects with normal range of Apo
A1 levels. Also, it is important to consider the inverse rela-
tionship between triglyceride and HDL and Apo A1 levels.
The rationale for not including triglyceride or HDL in the
model was as follows. The genomic profiles controlling
Apo A1 and triglyceride or HDL might be overlapped.
Adjusting triglyceride or HDL will eliminate the genetic
proportions of controlling HDL and triglyceride, and a
part of Apo A1 levels. It was contradictory to our primary
hypothesis to explore the genetic components of Apo A1
levels. Therefore, the genetic results may be confounded
by triglyceride or HDL components, and did not separate
the background of specific traits.
Another possible reason for our failure to detect a major
gene effect for Apo A1 is the young age of our subjects. Age
plays an important role for genetic control on phenotype
expression, and environmental factors add complication
in lipid traits. A recent study on the effect of quantitative
trait loci for lipid phenotypes in the rat indicated that
genetic components become important factors to the con-
trol of phenotype expression as age increases [25]. Among
human, Apo A1 was also reported to have intergenera-
tional differences in heritability [26]. However, lack of a
major gene in the study families does not exclude the pos-
sibility that there are major genes that will influence Apo
A1 levels in late adulthood. For example, there have been
reports suggesting pleiotropy affecting lipid-related traits
and obesity. Substantial evidence for quantitative trait loci
with pleiotropic effects influencing BMI and HDL were
Distribution of families favoring the environmental or Men- delian model in segregation analysis of residual Apo A in this  family study, presented by the -2ln(LE/LM) ratio, LE: likeli- hood of environmental model, LM: likelihood of Mendelian  model Figure 2
Distribution of families favoring the environmental or Men-
delian model in segregation analysis of residual Apo A in this 
family study, presented by the -2ln(LE/LM) ratio, LE: likeli-
hood of environmental model, LM: likelihood of Mendelian 
model.BMC Genetics 2006, 7:4 http://www.biomedcentral.com/1471-2156/7/4
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found in the Framingham Heart Study [40]. We con-
ducted analyses with BMI as a covariate. If pleiotropy
exists affecting body weight and lipid-related traits, adjust-
ing for BMI would likely hide the genetic effect on ApoA1.
This could explain why our study did not identify a major
gene contribution. Finally, we have collected several items
about food intakes among the family members, such as
vegetarian, meats, and rice amounts. The high spouse cor-
relation coefficient was not associated with above varia-
bles. It is the limitation of our study to explain the
possible common household effects on Apo A1 levels.
Segregation analysis is typically very sensitive to ascertain-
ment, and false assumptions on ascertainment could
invalidate the estimates obtained through segregation
analysis (11). Highly selected samples obtained through a
phenotype-based ascertainment scheme may lead to
biased estimates. Therefore, the ascertainment scheme is
very important on segregation analysis. Although we did
not ascertain probands on ApoA1 trait, the likelihoods
corrected for ascertainment on probands' ApoA1 levels
provided efficient estimation. The results of likelihood
without correction of proband ascertainment were similar
to corrected likelihood results.
Complex segregation analysis was used to ask whether an
inheritable trait is controlled by a single major gene plus
residual polygenes, if so, gene mapping tasks would be
warranted. If not, gene mapping studies would be lack of
power because traditional statistical programs and sparse
genetic markers would not provide sufficient tools to
tackle a trait without major gene effects. However, this sit-
uation has changed in the past few years. Now we know a
complex trait is less likely to be influenced by a single
major gene. Advanced statistical programs, dense genetic
markers plus other new technologies has allowed us to
investigate a complex trait where genes with small to
moderate effects. In the post-genomics era, segregation
analysis is considered as an intermediate tool to help
investigators to plan further sophisticated genomic stud-
ies. Although the method did not give information of
exact DNA locus to find the genes, it can provide heritabil-
ity estimates and parameters for further parametric link-
age analysis. So segregation analysis should be useful and
not obsolete. Further genotype-based methods such as
linkage and association will be planned for elucidating
genetic effects and locations.
The large proportion of un-response parents was the lim-
itation of the study. Only 60% parents attended the study.
The causes of low response rates were as follows. First, the
parents were in the productive age (mean 44 years old)
and they felt they were relatively healthy and were not
interested in the health checkup. Second, the medical his-
tory rates of atherosclerotic disease among participant
parents were very low. We found there were 6% partici-
pant parents who knew their hyperlipidemia disease, and
less than 1% had history of coronary heart disease.
Although we cannot collect the data on un-response par-
ents, we have checked the questionnaires of lifestyle pat-
terns from the probands, and found the distributions of
socioeconomic status and lifestyle patterns were similar
between response and non-response parents. It might
imply the response parents can be the representatives of
all parents.
Conclusion
Variations of Apo A1 levels in the normal range, especially
during adolescence, are likely to be influenced by multi-
ple factors without significant contribution from major
genes.
Methods
Subjects
This family study was part of the Chin-San Community
Cardiovascular Study, a prospective cohort study began in
1990 [27,28]. The family study arm started in 1997 and
was designed to recruit adolescent probands from stu-
dents in the only junior high school in the community. At
first, a total of 1063 students (response rate 94.6%) agreed
to participate in a general health check-up after informed
consent was obtained. They underwent examinations for
anthropometric measures, blood pressure, and lipid pro-
files, including total cholesterol, triglyceride, low density
lipoprotein (LDL) cholesterol, body mass index, systolic
pressure, diastolic pressure, and high density lipoprotein
(HDL) cholesterol. The high-risk young probands were
defined as the highest scores of above seven measures,
which were 90th  percentile values among all subjects
(HDL as below 10th percentile, n = 171). The control
young probands were ascertained by random sampling of
other young students (n = 197). Because the original strat-
ification was not based exclusively on the Apo A1 and the
results of CSA for the families of the two strata were simi-
lar, only the results of all families together with correction
for ascertainment on proband's Apo A1 were reported in
this study. After obtaining informed consent from
probands' family members, the same measures were per-
formed for each family member. Only first-degree rela-
tives were included for this genetic study, with a total of
1,145 subjects.
Measurement of lipid profiles
The measurement of various lipid profiles have been
described in detail elsewhere [29]. Briefly, a blood sample
of 20 ml was drawn from each participant after a 12-hour
overnight fast. Enzymatic methods were used to deter-
mine serum cholesterol and triglyceride (Merck 14354
and 14366 Germany, respectively). The HDL-C level was
measured in the supernatant after precipating with mag-BMC Genetics 2006, 7:4 http://www.biomedcentral.com/1471-2156/7/4
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nesium chloride phosphotungstate reagents (Merck
14993, Germany). The LDL-C content was measured as
"total cholesterol minus cholesterol in the supernatant"
by the precipitation method [30]. (Merck 14992, Ger-
many). If the triglyceride concentration was more than
400 mg/dL, cholesterol was measured from an infranate
density more than 1.006 from ultracentrifugation [31].
Apo A1 and B concentrations were measured by turbidi-
metric immunoassay using commercial kits (Sigma,
USA). The standard samples for apolipoprotein assay
were from the Center for Disease Control, USA. The coef-
ficient of variation of Apo A1 measured in our laboratory
was less than 3%. If extreme values were found, repeated
measures were done for confirmation. All measures were
performed in July and August, and hence seasonal varia-
tion could be minimized.
Statistical analyses
We adjusted a person's Apo A1 concentrations for known
determinants by regressing for age, gender, body mass
index (BMI), smoking and alcohol drinking status. Both
age and BMI were centered by subtracting the sample
mean, 34.0 for age and 22.3 for BMI, from the corre-
sponding variables. Residual values plus the sample mean
of Apo A1 (116.8 mg/dL) were then used for further anal-
yses.
The correlations of Apo A1 concentrations between
mother-father, parent-offspring, and siblings were esti-
mated by using the FCOR program in SAGE [32]. Next,
commingling analysis of Apo A1 levels was performed
using the ADMIX program to test whether the data were
best described by one, two, or more component distribu-
tions [33]. The parameters for each component's mean,
variance, and proportion were estimated by the maximum
likelihood method. Hypothesis testing for nested models
was carried out with the likelihood ratio test.
Complex segregation analysis
Segregation analysis of Apo A1 levels was conducted using
regressive models as implemented in the REGC program
in SAGE These models assume that variation of Apo A1
concentration among family members is the result of a
major gene effect, with the residual variation reflecting
both familial correlations and individual variation. The
presence of a major gene is assessed by allowing two fac-
tors or alleles (A and B) at a single locus, resulting in three
'ousiotypes' (AA, AB, BB) in individuals (Cannings et al.
1977). The means of Apo A1 for each ousiotype is
denoted AA, AB, BB, with one common variance of σ2.
The frequencies of allele A and B are denoted qA and (1-
qA), respectively. The distribution of types in the popula-
tion is assumed to be in Hardy-Weinberg equilibrium.
Individuals of each type are assumed to transmit allele A
to their offspring with transmission probabilities τAA,
τAB and τBB, respectively. Residual familial resemblance
not explained by this major locus is modeled by familial
correlations. The correlation between spouses, parent and
offspring, mother and offspring, father and offspring, and
between siblings, are denoted ρMF, ρPO, ρMO, ρFO, and
ρSS, respectively. For this study, we adopted class D
regressive models, in which residual sib-sib correlations
are equal among all sibs of common parentage and can be
due to any cause. If ρPO is held equal to ρSS, these models
have been shown to be mathematically and numerically
equivalent to the conventional mixed model of inherit-
ance in nuclear families [34]. Under this circumstance, the
heritability can be estimated by 2ρSS(σ2/σ2T), where σ2T
is the total variance, and σ2 is the variance conditional on
the major ouisotype [34].
The analyses started with fitting a general model, in which
all parameters were allowed to be estimated. Then we
compared the general model with various submodels in
which certain parameters were restricted to specific values.
Under a Mendelian model, the transmission probabili-
ties, i.e., τAA, τAB and τBB, were held equal to Mendelian
expectations of 1, 0.5, and 0. A nontransmitted environ-
mental effect model predicts that the probability that an
individual has one ousiotype or another is independent of
both the person's generation and the ousiotypes of his/her
parents. For the environmental model in this study, each
of the transmission probabilities is taken to be equal to
the factor frequency, i.e., τAA = τAB = τBB = qA. Both the
Mendelian and environmental models can allow for resid-
ual familial correlations. A pure polygenic model assumes
no major gene effect, so gene frequency and transmission
probabilities are all fixed to one. The fit of hierarchical
models is compared with the likelihood ratio test, calcu-
lated as -2 of the difference between the ln likelihood of
the models being compared. The likelihood ratio value
follows a chi-square distribution, with degrees of freedom
equal to the difference between the models in the number
of parameters estimated. Among nonhierarchical models,
the most parsimonious model is that with the lowest val-
ues of Akaike's information criterion (AIC = -2 ln likeli-
hood + 2 [number of estimated parameters]) [35].
We used the adjusted Apo A1 values without logarithm
transformation for the segregation analysis because nor-
malizing transformation of a biologically skewed trait
would decrease power to detect a major gene effect when
one exists [36]. Instead, we fit the environmental model.
If such a model can be rejected, the major gene effect will
not be due to skewness of the residual Apo A1 levels [37].
Ascertainment correction was conducted by conditioning
on the phenotypes of probands.
A sensitivity test of the model fitting, specified by initial
values of gene frequency, was performed to differentiateBMC Genetics 2006, 7:4 http://www.biomedcentral.com/1471-2156/7/4
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local maxima from global maximum [38]. We calculated
the -2lnL values by setting initial gene frequency to values
ranging from 0.01 to 0.99, in steps of 0.01, and fixed ini-
tial means, variance, and familial correlations. We com-
pared likelihood values of two models and calculated the
ratio of log likelihood values to detect possible heteroge-
neity [7,39].
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